Anna McNaughton
PhD
Postdoctoral Scientist
I am a postdoctoral researcher in the Matthews Group working on hepatitis B virus (HBV), with a focus on populations in Southern Africa. I am working on the development of deep sequencing pipelines for whole genome sequencing of HBV, using both Illumina and Nanopore platforms.
My research interests span a number of fields including the development of viral sequencing methods, blood-borne viral infections, pathogen transmission, viral diversity and evolution, as well as international health and infectious disease epidemiology.
Prior to working at Oxford, I studied at the University of Bristol, the London School of Hygiene and Tropical Medicine, and I undertook my PhD studies on hepatitis C virus (HCV) at the MRC Centre for Virus Research at the University of Glasgow.
Key publications
-
Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
Journal article
McNaughton AL. et al, (2020), PLoS Med, 17
-
HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model.
Journal article
McNaughton AL. et al, (2019), BMC Med, 17
-
Rolling circle amplification and nanopore-based deep sequencing of full-length HBV genomes
Conference paper
Mcnaughton A. et al, (2018), JOURNAL OF HEPATOLOGY, 68, S762 - S762
-
Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.
Journal article
McNaughton AL. et al, (2019), Gastroenterology, 156, 384 - 399
-
Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.
Journal article
McNaughton AL. et al, (2015), J Virol, 89, 11223 - 11232
Recent publications
-
Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
Journal article
Wang T. et al, (2020)
-
Extending treatment eligibility for chronic hepatitis B virus infection.
Journal article
McNaughton AL. et al, (2020), Nat Rev Gastroenterol Hepatol
-
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis.
Journal article
Campbell C. et al, (2020), J Viral Hepat
-
Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
Journal article
Downs LO. et al, (2020), Wellcome Open Research, 5, 240 - 240
-
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
Journal article
Campbell C. et al, (2020)